Results 11 to 20 of about 33,834 (215)

Percutaneous Direct Puncture of Retropancreatic Splenic Vein and Portal Thrombectomy in a Patient With Liver Transplantation and Simultaneous Splenectomy

Transplantation Direct, 2023
Portal vein thrombosis following liver transplantation is generally managed by endovascular treatment. Although several techniques are available for portal venous access, trans-splenic access is of interest because it avoids damage to the liver graft ...
Takanobu Hara, MD, PhD, Akihiko Soyama, MD, PhD, Hideki Ishimaru, MD, PhD, Hajime Matsushima, MD, PhD, Hajime Imamura, MD, PhD, Shuto Miyamura, MD, Takashi Hamada, MD, PhD, Kunihito Matsuguma, MD, Masayuki Fukumoto, MD, Takayuki Tanaka, MD, PhD, Tomohiko Adachi, MD, PhD, Masaaki Hidaka, MD, PhD, Susumu Eguchi, MD, PhD   +12 more
doaj   +1 more source

ROLE OF COLOR DOPPLER ULTRASONOGRAPHY VERSUS TRIPHASIC CT WITH PORTOGRAPHY IN PORTAL VEIN THROMBOSIS [PDF]

Ain Shams Medical Journal, 2020
Back ground: Although portal vein thrombosis is a rare event among general population, its prevalence in cirrhotic patients about 28 % (1). Generally liver cirrhosis is a widespread disease, the differentiation between bland and malignant thrombus is ...
Khaled Ali, Mohamed Hassan, Maha Abdelraof, Eman Abdelsalam   +3 more
doaj   +1 more source

Successful heparin-perfusion therapy for complete thrombosis of the intra- and extrahepatic portal and mesenteric vein. A case report and literature review

Radiology Case Reports, 2023
The initial treatment of acute and subacute portal vein thrombosis, which is the most common cause of portal vein occlusion, consists of intravenous anticoagulation with heparin, but there is still a huge uncertainty among physicians regarding the role ...
Mohammed Misbahuddin-Leis, MBBS, Burhan Ademi, MS, Muzaffer Ankolvi, MBBS, Krisztina Dubasz, MD, Manisha Mishra, MBBS, Maren Riechmann, MS, Christian Graeb, MS, Boris Radeleff, MD, EBIR   +7 more
doaj   +1 more source

Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study

Hepatology, EarlyView., 2022
A deleterious variant of FCHSD1 results in mTOR pathway overactivation and may cause porto‐sinusoidal vascular disorder (PSVD). The pedigree of the family demonstrated an autosomal dominant disease with variable expressivity. Whole‐genome sequencing and Sanger sequencing both validated the existence of the FCHSD1 variant and the heterozygosity of c ...
Jingxuan Shan, André Megarbane, Aziz Chouchane, Deepak Karthik, Ramzi Temanni, Atilio Reyes Romero, Huiying Hua, Chun Pan, Xixi Chen, Murugan Subramanian, Chadi Saad, Hamdi Mbarek, Cybel Mehawej, Eliane Chouery, Sirin W. Abuaqel, Alexander Dömling, Sami Remadi, Cesar Yaghi, Pu Li, Lotfi Chouchane   +19 more
wiley   +1 more source

New classification‐oriented treatment strategy for portal vein thrombosis after hepatectomy

Annals of Gastroenterological Surgery, 2020
Aim This study sought to evaluate the incidence, risk factors, and clinical outcomes of portal vein thrombosis after hepatectomy. Furthermore, we proposed a novel classification and treatment strategy for portal vein thrombosis after hepatectomy. Methods
Shinji Onda, Kenei Furukawa, Yoshihiro Shirai, Ryoga Hamura, Takashi Horiuchi, Jungo Yasuda, Hironori Shiozaki, Takeshi Gocho, Hioaki Shiba, Toru Ikegami   +9 more
doaj   +1 more source

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

Hepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree   +19 more
wiley   +1 more source

MRI diffusion-weighted imaging detects a fresh portal vein thrombus as a high intensity lesion in a patient with a liver transplant: A case report

Acta Radiologica Open, 2021
Portal vein thrombosis is one of the most serious complications after liver transplantation. It is important to determine the age of the thrombus for management of portal vein thrombosis.
Yasuyoshi Kuroiwa, Kazunori Kusumoto, Keita Shimata, Atsushi Yamashita, Taizo Hibi, Yujiro Asada, Takuroh Imamura   +6 more
doaj   +1 more source

Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury

Hepatology, EarlyView., 2022
Diagnostic and prognostic ability of urinary NGAL in patients with cirrhosis and AKI. Abstract Background and Aims Acute kidney injury (AKI) commonly occurs in patients with decompensated cirrhosis. Urinary neutrophil gelatinase–associated lipocalin (uNGAL) could help discriminate between different etiologies of AKI.
Carmine Gambino, Salvatore Piano, Matteo Stenico, Marta Tonon, Alessandra Brocca, Valeria Calvino, Simone Incicco, Nicola Zeni, Roberta Gagliardi, Chiara Cosma, Martina Zaninotto, Patrizia Burra, Umberto Cillo, Daniela Basso, Paolo Angeli   +14 more
wiley   +1 more source

Portal Vein Thrombosis in Cirrhosis [PDF]

Journal of Clinical and Experimental Hepatology, 2014
Portal vein thrombosis (PVT) is being increasingly recognized in patients with advanced cirrhosis and in those undergoing liver transplantation. Reduced flow in the portal vein is probably responsible for clotting in the spleno-porto-mesenteric venous system. There is also increasing evidence that hypercoagulability occurs in advanced liver disease and
Kaiser, Raja, Mathew, Jacob, Sonal, Asthana   +2 more
openaire   +2 more sources

Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study

Thrombosis Journal, 2023
Background Portal vein thrombosis is a common complication of liver cirrhosis and hepatocellular carcinoma; however, few studies have reported its long-term clinical prognosis.
Xuan Zhong, Shan Li, Jiali Hu, Jinlai Lu, Wei Wang, Miao Hu, Qinjuan Sun, Shuo Zhang, Xiaoqing Yang, Changqing Yang, Lan Zhong   +10 more
doaj   +1 more source